If you have been reading about lyophilized powder and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-09-28. Where a claim depends on a specific study, the study is described rather than over-claimed.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Derived from C-terminal region of human growth hormone |
| Approximate molecular mass | About 1.8 kDa | Varies with sequence length and counterions |
| Confirmed receptor target | None established | No confirmed growth hormone receptor agonism |
| Reported in vitro activity | Lipolysis stimulation and lipogenesis inhibition | Observed mainly in adipocyte models; human relevance uncertain |
| Regulatory status | Not approved as a drug in major markets | May be treated differently across jurisdictions; not a recognized dietary ingredient in some countries |
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
Trump and his administration's Make America Healthy Again agenda promoted various anti-science and anti-vaccine claims, which led to a resurgence of whooping cough and measles. They alleged they were working against Big Pharma. On November 14, Trump announced that he would nominate Robert F. Kennedy Jr. for Health and Human Services Secretary. This was controversial given Kennedy's repeated endorsement of anti-vaccine conspiracy theories. The director of the American Public Health Association, America's largest organization of public health professionals, said, "He is not competent by training, management skills, temperament or trust to have this job." On February 18, Trump signed an executive order calling for the policy recommendations for reducing the out-of-pocket costs of In Vitro Fertilisation. On February 25, Trump signed an executive order to improve healthcare cost transparency.
== Sources == Johnson, Daniel; Hashaikeh, Raed; Hilal, Nidal (2021). "Basic principles of osmosis and osmotic pressure". In Hilal, Nidal; Ismail, Ahmad Fauzi; Khayet, Mohamed; Johnson, Daniel (eds.). Osmosis Engineering. Elsevier. pp. 1–15. doi:10.1016/B978-0-12-821016-1.00011-5. ISBN 978-0-12-821016-1.
An alternative to solvent-based extraction for particulates on filters is the use of thermal extraction (TE)-GC/MS, which utilizes oven interfaced with the GC inlet to vaporize the analyte of the sample and into the GC inlet. This technique is more often used then solvent-based extraction, because of its better sensitivity, eliminates need for solvents, and can be fully automated. To increase the separation of the particles the GC can be coupled with a time of flight (TOF)-MS, which is a mass separation method that separates ions based on their size. Another method that utilizes EI is isotope ratio mass spectrometry (IR-MS) this instrumentation incorporates a magnetic sector analyzer and a faraday-collector detector array and separates ions based on their isotopic abundance. Isotopic abundance of carbon, hydrogen, nitrogen, and oxygen isotopic abundance become locally enriched or depleted through a variety of atmospheric processes. This information helps in determining the source of the aerosols and the interaction it has had. EI is a universal ionization method, but it does cause excessive fragmentation, and thus can be substituted with chemical ionization (CI) which is a much softer ionization method, and is often used to determine the molecular ion. One ionization method the utilizes CI is atmospheric-pressure chemical ionization (APCI).
Sources: en.wikipedia.org
During the separation, the mobile phase composition may stay the same, or change. If it stays the same, the process is termed isocratic (meaning constant composition). The word was coined by Csaba Horvath who was one of the pioneers of HPLC. If it changes, then the process is termed a gradient elution. For example, a gradient can start at 10% methanol in water, and end at 90% methanol in water after 20 minutes. The two components of the mobile phase are typically termed "A" and "B"; A is the "weak" solvent which allows the solute to elute only slowly, while B is the "strong" solvent which rapidly elutes the solutes from the column. In reversed-phase chromatography, solvent A is often water or an aqueous buffer, while B is an organic solvent miscible with water, such as acetonitrile, methanol, THF, or isopropanol. In isocratic elution, peak width increases with retention time linearly according to the equation for N, the number of theoretical plates. This can be a major disadvantage when analyzing a sample that contains analytes with a wide range of retention factors. Using a weaker mobile phase, the runtime is lengthened and results in slowly eluting peaks to be broad, leading to reduced sensitivity. A stronger mobile phase would improve issues of runtime and broadening of later peaks but results in diminished peak separation, especially for quickly eluting analytes which may have insufficient time to fully resolve. This issue is addressed through the changing mobile phase composition of gradient elution.
AAS that have a high potential for aromatization like testosterone and particularly methyltestosterone show a high risk of gynecomastia at sufficiently high dosages, while AAS that have a reduced potential for aromatization like nandrolone show a much lower risk (though still potentially significant at high dosages). In contrast, AAS that are 4,5α-reduced, and some other AAS (e.g., 11β-methylated 19-nortestosterone derivatives), have no risk of gynecomastia. In addition to gynecomastia, AAS with high estrogenicity have increased antigonadotropic activity, which results in increased potency in suppression of the hypothalamic–pituitary–gonadal axis and gonadal testosterone production.
MS1 data refers mainly to the isotope pattern of the compound. Due to the natural isotopic distributions of the elements, several peaks in the mass spectrum correspond to the same type of sample molecule, reflecting its isotope pattern. MS2 data refers to the fragmentation pattern of the compound. MS2 is also known as tandem mass spectrometry or MS/MS. The statistical model of SIRIUS and the machine learning model of CSI:FingerID were trained on MS2 spectra created by collision-induced dissociation (CID), as commonly applied in LC-MS/MS experiments. SIRIUS expects both, MS1 and MS2 spectra, as input. Omitting the MS1 data is possible, but it will make the analysis more time-consuming and can lead to poorer results. SIRIUS and CSI:FingerID have been trained on a wide variety of data, including data from different instrument types. Certain aspects of the mass spectra are important to successfully process the data:
==== Germany ==== In Germany all of the major parties are loosely associated with research foundations that play some role in shaping policy, but generally from the more disinterested role of providing research to support policymakers than explicitly proposing policy. These include the Konrad-Adenauer-Stiftung (Christian Democratic Union-aligned), the Friedrich-Ebert-Stiftung (Social Democratic Party-aligned), the Hanns-Seidel-Stiftung (Christian Social Union-aligned), the Heinrich-Böll-Stiftung (aligned with the Greens), Friedrich Naumann Foundation (Free Democratic Party-aligned) and the Rosa Luxemburg Foundation (aligned with Die Linke). The German Institute for International and Security Affairs is a foreign policy think tank. Atlantic Community is an independent, non-partisan and non-profit organization set up as a joint project of Atlantische Initiative e.V. and Atlantic Initiative United States. The Institute for Media and Communication Policy deals with media-related issues. Transparency International is a think tank on the role of corporate and political corruption in international development.
Sources: en.wikipedia.org
== Treatment == Each body is different, and no single formula works for all. People with Lipedema are encouraged to slowly incorporate different treatments into their routine to see what best works for them. The primary goals of treating Lipedema are to: manage inflammation, reduce fibrosis, decrease adipose tissue, improve lymphatic flow, increase mobility, minimize fatigue, manage pain, prioritize emotional and mental health, and promote overall health. Several treatments may be useful including physiotherapy and light exercise which does not put undue stress on the lymphatic system. The two most common conservative treatments are manual lymphatic drainage (MLD) where a therapist gently opens lymphatic channels and moves the lymphatic fluid using hands-on techniques, and compression garments that keep the fluid at bay and assist the sluggish lymphatic flow. Pneumatic compression device or “pump” is useful if there is a lot of swelling or for pain control. The use of surgical techniques is not universal but research has shown positive results in both short-term and long-term studies regarding lymph-sparing liposuction and lipectomy. The studies of the highest quality involve tumescent local anesthesia (TLA), often referred to as simply tumescent liposuction. This can be accomplished via both Suction-Assisted Liposuction (SAL) and Power-Assisted (vibrating) liposuction. The treatment of lipedema with tumescent liposuction may require multiple procedures.
=== Eye health === Nicotinamide has potential benefit in slowing vision loss and providing protection of eye cells, with the most promising evidence for protecting the retina from normal‑tension glaucoma and optic nerve from other forms of glaucoma. Relevant studies in the scientific literature speculate the mechanism of action to be direct retinal ganglion cell protection, among other indirect pathways in the optical nervous system. Contrary to nicotinamide, niacin has not been found to possess any properties in protecting optical nerve components as of 2026. Current research studies and American Academy of Ophthalmology have suggested a total daily intake of 1000mg, with optimal interval doses of 500mg spread throughout the day in promoting eye health.
== Applications == Ammonium sulfate precipitation is a useful technique as an initial step in protein purification because it enables quick, bulk precipitation of cellular proteins. It is also often employed during the later stages of purification to concentrate protein from dilute solution following procedures such as gel filtration. The drawback of this method is that oftentimes different substances can precipitate along with the protein, and other purification techniques must be performed, such as ion chromatography or size-exclusion chromatography.
Sources: en.wikipedia.org
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.
It is not approved as a prescription drug in the United States or the European Union for any indication. Regulatory status can differ by country, and it is often sold as a research chemical or in unapproved products. Such products are not equivalent to an approved medicine.
In the studies reported so far, AOD9604 does not appear to act through the growth hormone receptor and has not shown the typical IGF-1 increase caused by full-length hGH. Human data are limited, so this remains an area of uncertainty. It should not be assumed to have the same effects as hGH.
Lyophilized powder is commonly stored at −20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept refrigerated and used within a limited period.